PharmTech Europe News

May 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.
May 08, 2015
Novartis announces that its lung cancer drug, Zykadia, gained European Union approval.
May 02, 2015
Pharmaceutical Technology
The restructuring of the International Conference on Harmonization, which is expected to begin in late 2015, could have a significant impact on the way pharmaceutical regulations are harmonized worldwide.
Apr 22, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
The past six months has seen some major changes to the sterile manufacturing landscape in Europe. There have been a number of exits and acquisitions that have no doubt grabbed headlines, but has anything really changed?
Apr 02, 2015
Pharmaceutical Technology Europe
A review of some of the latest packaging and drug-delivery innovation presented at Pharmapack Europe.
Apr 02, 2015
Pharmaceutical Technology Europe
As the prevalence of falsified medicines continues to increase, Switzerland is taking measures to secure its supply chain such as the implementation of serialization.
Apr 02, 2015
Pharmaceutical Technology Europe
The authors outline a validation approach for the manufacture of a “legacy product,” taking into consideration recent guidelines. The aim is to demonstrate the validity and capacity of the manufacturing process following a change in the manufacturer.
Apr 02, 2015
Pharmaceutical Technology
Drug developers understand the importance of early communication with regulators, but is EMA providing enough flexibility and support to companies?
Mar 02, 2015
Pharmaceutical Technology
Proposals to make the decentralized procedure more efficient were discussed at the January 2015 EGA conference.
Jan 23, 2015
By Pharmaceutical Technology Editors
EMA Recommends Suspension of 700 Drugs Tested at GVK Site GVK Biosciences argues that EMA’s recommended suspension of 700 drugs is disproportional to reported infractions.
native1_300x100
lorem ipsum